HAEMONETICS CORP Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Haemonetics Corp quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Haemonetics Corp Goodwill for the quarter ending September 28, 2024 was $616M, a 32.4% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $616M +$151M +32.4% Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $613M +$147M +31.6% Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $565M +$98.9M +21.2% Mar 30, 2024 10-Q 2024-11-07
Q4 2023 $555M +$88.9M +19.1% Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $465M +$418K +0.09% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $466M -$205K -0.04% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 $466M -$1.06M -0.23% Apr 1, 2023 10-K 2024-05-20
Q4 2022 $466M -$2.09M -0.45% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $465M -$3.6M -0.77% Oct 1, 2022 10-Q 2022-11-08
Q2 2022 $466M -$199K -0.04% Jul 2, 2022 10-Q 2022-08-10
Q1 2022 $467M +$843K +0.18% Apr 2, 2022 10-K 2024-05-20
Q4 2021 $468M +$253M +117% Jan 1, 2022 10-Q 2022-02-08
Q3 2021 $469M +$254M +118% Oct 2, 2021 10-Q 2021-11-09
Q2 2021 $466M +$249M +115% Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $466M +$256M +121% Apr 3, 2021 10-K 2023-05-22
Q4 2020 $216M +$4.45M +2.11% Dec 26, 2020 10-Q 2021-02-02
Q3 2020 $215M +$3.55M +1.68% Sep 26, 2020 10-Q 2020-11-04
Q2 2020 $217M +$6.16M +2.92% Jun 27, 2020 10-Q 2020-08-04
Q1 2020 $211M -$167K -0.08% Mar 28, 2020 10-K 2022-05-25
Q4 2019 $211M +$339K +0.16% Dec 28, 2019 10-Q 2020-02-04
Q3 2019 $211M +$197K +0.09% Sep 28, 2019 10-Q 2019-11-01
Q2 2019 $211M +$237K +0.11% Jun 29, 2019 10-Q 2019-08-06
Q1 2019 $211M -$576K -0.27% Mar 30, 2019 10-K 2021-05-26
Q4 2018 $211M -$363K -0.17% Dec 29, 2018 10-Q 2019-02-05
Q3 2018 $211M -$281K -0.13% Sep 29, 2018 10-Q 2018-11-06
Q2 2018 $211M -$27K -0.01% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $211M +$554K +0.26% Mar 31, 2018 10-K 2020-05-20
Q4 2017 $211M -$56.2M -21% Dec 30, 2017 10-Q 2018-02-06
Q3 2017 $211M -$57.4M -21.4% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $211M -$57.7M -21.5% Jul 1, 2017 10-Q 2017-08-07
Q1 2017 $211M -$57M -21.3% Apr 1, 2017 10-K 2019-05-22
Q4 2016 $267M +$369K +0.14% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 $269M -$65M -19.5% Oct 1, 2016 10-Q 2016-11-07
Q2 2016 $269M -$65.6M -19.6% Jul 2, 2016 10-Q 2016-08-01
Q1 2016 $268M -$66.5M -19.9% Apr 2, 2016 10-K 2018-05-23
Q4 2015 $267M -$68M -20.3% Dec 26, 2015 10-Q 2016-02-02
Q3 2015 $334M -$2.73M -0.81% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 $334M -$3.05M -0.9% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 $334M -$2.46M -0.73% Mar 28, 2015 10-K 2017-05-24
Q4 2014 $335M -$2.04M -0.61% Dec 27, 2014 10-Q 2015-02-05
Q3 2014 $336M -$5.37M -1.57% Sep 27, 2014 10-Q 2014-11-04
Q2 2014 $337M -$4.27M -1.25% Jun 28, 2014 10-Q 2014-07-31
Q1 2014 $337M +$6.29M +1.91% Mar 29, 2014 10-K 2016-06-01
Q4 2013 $337M +$15.7M +4.9% Dec 28, 2013 10-Q 2014-01-30
Q3 2013 $342M +$19.6M +6.07% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 $342M +$226M +197% Jun 29, 2013 10-Q 2013-08-02
Q1 2013 $330M +$215M +187% Mar 30, 2013 10-K 2015-05-22
Q4 2012 $321M +$206M +179% Dec 29, 2012 10-Q 2013-02-01
Q3 2012 $322M +$207M +179% Sep 29, 2012 10-Q 2012-11-07
Q2 2012 $115M -$659K -0.57% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $115M -$309K -0.27% Mar 31, 2012 10-K 2014-05-22
Q4 2011 $115M +$4.05M +3.64% Dec 31, 2011 10-Q 2012-02-06
Q3 2011 $116M +$3.2M +2.85% Oct 1, 2011 10-Q 2011-11-03
Q2 2011 $116M -$2.03M -1.73% Jul 2, 2011 10-Q 2011-08-10
Q1 2011 $115M +$5.38M +4.89% Apr 2, 2011 10-K 2013-05-20
Q4 2010 $111M Jan 1, 2011 10-Q 2011-02-08
Q3 2010 $112M Oct 2, 2010 10-Q 2010-11-10
Q2 2010 $118M Jul 3, 2010 10-Q 2010-08-11
Q1 2010 $110M Apr 3, 2010 10-K 2012-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.